Maternal immunization: The influence of liability issues on vaccine development

Vaccine

Volumn 20, Issue SUPPL. 1, 2001, Pages

  Paradiso, Peter R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MATERNAL ANTIBODY; POLIOMYELITIS VACCINE; TETANUS TOXOID; VACCINE;

ARTICLE; CHILD; CHILD DEATH; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; HAEMOPHILUS INFLUENZAE TYPE B; HOSPITALIZATION; HUMAN; IMMUNIZATION; LOWER RESPIRATORY TRACT INFECTION; MATERNAL CARE; NEWBORN; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STREPTOCOCCUS AGALACTIAE; VACCINE PRODUCTION;

FEMALE; HUMANS; IMMUNIZATION; JURISPRUDENCE; PREGNANCY; VACCINES;

EID: 0035888302     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00302-4     Document Type: Article

References (10)

1. The potential for maternal immunization to protect against neonatal infections
2. The prevention of neonatal tetanus by maternal immunization
3. Prevention and control of influenza: Recommendations of the Advisory Committee on immunization practices (ACIP)
4. Bronchiolitis-associated hospitalizations among US children, 1980-1996
5. Risk of respiratory syncytial virus infection for infants from low-income families in relation to age, sex, ethnic group, and maternal antibody level
6. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
7. Correlation between low levels of maternal IgG antibodies to group B streptococcal (GBS) polysaccharides and susceptibility of neonates to early-onset GBS disease: A case-control study
8. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month-old infants
9. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B streptococcus in healthy women
10. Group B streptococcal disease in the era of intrapartum antiobiotic prophylaxis